Perioperative management of the rheumatic disease patient

Bulletin on the Rheumatic Diseases

Volumn 51, Issue 6, 2002, Pages

  Kelley III, Joe T ^a   Conn, Doyt L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYCHLOROQUINE; IBUPROFEN; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; ROFECOXIB; SALAZOSULFAPYRIDINE; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VALDECOXIB;

ANAMNESIS; ATLANTOAXIAL SUBLUXATION; BLEEDING; BLEEDING TIME; CHOLECYSTECTOMY; CLINICAL TRIAL; ESOPHAGUS DISEASE; EXERCISE; FEVER; FRAGILITY FRACTURE; GASTROENTERITIS; HALF LIFE TIME; HEART VENTRICLE OVERLOAD; HEMICOLECTOMY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; IMMUNE DEFICIENCY; INFECTION; JOINT CONTRACTURE; LABORATORY TEST; MOBILIZATION; NECK PAIN; OSTEOPOROSIS; PAIN; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; PHYSIOTHERAPIST; PNEUMONIA; POSTOPERATIVE COMPLICATION; PSYCHOSIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEPSIS; SHOCK; SUPPLEMENTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE AGGREGATION; URINARY EXCRETION; WOUND HEALING IMPAIRMENT; X RAY;

EID: 0043286174     PISSN: 00075248     EISSN: 00075248     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Schafer AI. Effects of nonsteroidal anti-inflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995;35:209-19.
2. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991;77:2547-51.
3. Gewirtz AS, Miller ML, Keys TF. The clinical usefulness of the preoperative bleeding time. Arch Pathol Lab Med 1996;120:353-6.
4. Connelly CS, Panush RS. Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch Intern Med 1991;151:1963-6.
5. Robinson CM, Christie J, Malcolm-Smith N. Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty 1993;8:607-10.
6. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002;287:236-40.
7. Lamberts SWJ, Bruining HA, DeJong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997;337:1285-92.
8. Salem M, Tainsh RE, Bromberg J, et al. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg 1994;219:416-25.
9. Streck WF, Lockwood DW. Pitiutary adrenal recovery following short-term suppression with corticosteroids. Am J Med 1979;66:910-4.
10. Bridges SL Jr, Moreland LW. Perioperative use of methotrexate in patients with rheumatoid arthritis undergoing orthopedic surgery. Rheum Dis Clin North Am 1997;23:981-93.
11. Bridges SL Jr, Lopez-Mendez A, Han KH, et al. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 1991;18:984.
12. Perhala RS, Wilke WS, Clough JD, et al. Local infectious complications following knee joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 1991;34:146.
13. Kasdan ML, June L. Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 1993;16:1233.
14. Sany J, Anaya JM, Canovas F, et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 1993;20:1129.
15. Grennan DM, Gray J, Loudon J, et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Ann Rheum Dis 2001;60:214-7.
16. Smith MD, Ross W, Ahern MJ. Missing a therapeutic window of opportunity: An audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J Rheumatol 2001;28:2504-8.
17. Ross PD, Davis JW, Epstein RS, et al. Pre-existing fractures and bone mass predict fracture incidence in women. N Engl J Med 1995;332:767-73.
18. Owen RA, Melton LJ III, Ilstrup DM, et al. Colles' fracture and subsequent hip fracture risk. Clin Orthop Relat Res 1982;171:37-43.
19. Mallmin H, Ljunghall S, Persson I, et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993;52:269-72.
20. Khan SA, deGeus C, Holroyd B, et al. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med 2001;161:1309-12.
21. Freedman KB, Kaplan FS, Bilder WB, et al. Treatment of osteoporosis: Are physicians missing an opportunity? J Bone Joint Surg 2000;82-A:1063-70.
22. Broy SB, Bohren A, Harrington T, et al. Are physicians treating osteoporosis after hip fracture? Arthritis Rheum 2000;43:S203.
23. Conn DL. Resolved: Low-dose prednisone is indicated as standard treatment in patients with rheumatoid arthritis. Arthritis Rheum (Arthritis Care Res) 2001;45:462-7.
24. Gurley JP, Bell GR. The surgical management of patients with rheumatoid cervical spine disease. Rheum Dis Clin North Am 1997;23:317-32.
25. Rana NA. Natural history of atlantoaxial subluxation in rheumatoid arthritis. Spine 1989;14:1054-6.
26. Harris ED Jr. Clinical features of rheumatoid arthritis. In Ruddy S, Harris ED Jr, Sledge CB (eds). Kelley's Textbook of Rheumatology 6th ed. Philadelphi: WB Saunders, 2001, 967-1000.